| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Bolt Biotherapeutics, Inc.'s insiders have reduced their positions by a net 38,584 shares worth roughly $128K.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 85.8K | $563.8K | - | |
| CEO | 25.4K | $166.8K | - | |
| COO | 17.3K | $113.5K | - | |
| VP | 17.1K | $112.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 9, 2021 | Sofinnova Venture Partners X, L.P.55 | 10% Owner | Buy | 450,000 | $20.00 | $9,000,000.00 | +19.5% | |
| Feb 9, 2021 | Novo Holdings A/s57 | 10% Owner | Buy | 400,000 | $20.00 | $8,000,000.00 | +9.7% |